Evolution of clinical studies with high-dose cytosine arabinoside at the M.D. Anderson Hospital

Semin Oncol. 1985 Jun;12(2 Suppl 3):98-104.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Arabinofuranosylcytosine Triphosphate / metabolism
  • Chromosome Aberrations
  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects
  • Cytarabine / therapeutic use*
  • Drug Evaluation
  • Drug Resistance
  • Half-Life
  • Humans
  • Leukemia / drug therapy*
  • Leukemia / genetics
  • Leukemia / metabolism
  • Leukemia, Lymphoid / drug therapy
  • Leukemia, Myeloid / drug therapy
  • Leukemia, Myeloid, Acute / drug therapy
  • Prognosis
  • Time Factors

Substances

  • Cytarabine
  • Arabinofuranosylcytosine Triphosphate